KOREAN JOURNAL OF PHYSIOLOGY & PHARMACOLOGY

Scope & Guideline

Connecting researchers and professionals in the heart of pharmacology.

Introduction

Welcome to the KOREAN JOURNAL OF PHYSIOLOGY & PHARMACOLOGY information hub, where our guidelines provide a wealth of knowledge about the journal’s focus and academic contributions. This page includes an extensive look at the aims and scope of KOREAN JOURNAL OF PHYSIOLOGY & PHARMACOLOGY, highlighting trending and emerging areas of study. We also examine declining topics to offer insight into academic interest shifts. Our curated list of highly cited topics and recent publications is part of our effort to guide scholars, using these guidelines to stay ahead in their research endeavors.
LanguageEnglish
ISSN1226-4512
PublisherKOREAN JOURNAL OF PHYSIOLOGY & PHARMACOLOGY
Support Open AccessNo
CountrySouth Korea
TypeJournal
Convergefrom 1997 to 2024
AbbreviationKOREAN J PHYSIOL PHA / KOREAN J. PHYSIOL. PHARMACOL.
Frequency6 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressC/O EDITORIAL OFFICE, 448-13 SEOKYO-DONG, SEOUL, SOUTH KOREA

Aims and Scopes

The Korean Journal of Physiology & Pharmacology focuses on advancing the understanding of physiological and pharmacological mechanisms through innovative research and methodologies.
  1. Pharmacology and Drug Development:
    The journal extensively covers pharmacological studies, including drug discovery, development, and the mechanisms of action of various pharmacological agents.
  2. Physiological Mechanisms:
    Research on physiological processes, including cardiac, renal, and neural functions, is a core area, aiming to elucidate underlying mechanisms and their implications for health and disease.
  3. Disease Models and Therapeutics:
    The journal features studies utilizing various animal models to investigate disease mechanisms and potential therapeutic interventions, contributing to translational medicine.
  4. Molecular and Cellular Biology:
    Research involving molecular biology techniques, including gene expression studies, signaling pathways, and cellular responses, is prominent, highlighting the interplay between cellular mechanisms and pharmacological effects.
  5. Integrative and Systems Biology:
    The integration of physiological and pharmacological data at the systems level is a unique contribution of the journal, promoting a holistic understanding of biological functions.
Recent publications indicate a shift towards several trending and emerging themes that highlight the journal's adaptive focus on contemporary issues in physiology and pharmacology.
  1. Network Pharmacology and Systems Biology:
    There is a growing emphasis on network pharmacology approaches, reflecting an interest in understanding complex interactions within biological systems and drug actions.
  2. Mitochondrial and Metabolic Research:
    Emerging themes related to mitochondrial function and metabolic pathways are increasingly prevalent, indicating a focus on energy metabolism and its implications for various diseases.
  3. Neuropharmacology and Neuroinflammation:
    Research into neuropharmacological effects and the role of inflammation in neurological disorders is gaining traction, aligning with the rising global interest in brain health.
  4. Nano-Drug Delivery Systems:
    The exploration of novel drug delivery systems, particularly nano-formulations, reflects a trend towards improving therapeutic efficacy and reducing side effects.
  5. Chronic Disease Management and Therapeutics:
    There is a notable increase in studies addressing chronic diseases, including diabetes and cardiovascular disorders, emphasizing the need for innovative therapeutic strategies.

Declining or Waning

As the field evolves, certain areas of focus within the journal appear to be diminishing in prominence, reflecting changing research priorities and interests.
  1. Traditional Herbal Medicine:
    While previously a significant focus, research on traditional herbal medicines has decreased, possibly due to a shift towards more mechanistic and molecular studies.
  2. Basic Pharmacology without Clinical Relevance:
    Studies that focus solely on basic pharmacological principles without clear clinical implications or applications are becoming less common, as the journal increasingly emphasizes translational research.
  3. Lesser-Known Animal Models:
    Research employing less common animal models has waned, with a trend towards using more established models that provide clearer insights into human pathophysiology.

Similar Journals

NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY

Illuminating the Complexities of Drug Mechanisms
Publisher: SPRINGERISSN: 0028-1298Frequency: 12 issues/year

NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY is a prestigious journal published by SPRINGER, focusing on the dynamic fields of pharmacology and toxicology. With an ISSN of 0028-1298 and an E-ISSN of 1432-1912, this esteemed publication has been a staple in the scientific community since its inception in 1969, continuing to wield influence with a convergence of research that reaches through 2024. Ranked in the Q2 category for both medicine and pharmacology, it stands at an impressive 111th out of 313 in the Scopus rankings for pharmacology, reflecting its significant impact in the field. Though not offering open access, the journal remains a vital resource for researchers, professionals, and students seeking to explore groundbreaking studies and advancements in pharmacological science. With its high standards and comprehensive coverage, NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY is essential reading for those dedicated to understanding the mechanisms of drug action and the complexities of therapeutic interventions.

BIOLOGICAL & PHARMACEUTICAL BULLETIN

Advancing the Frontiers of Biomedicine and Drug Development
Publisher: PHARMACEUTICAL SOC JAPANISSN: 0918-6158Frequency: 12 issues/year

BIOLOGICAL & PHARMACEUTICAL BULLETIN, published by the PHARMACEUTICAL SOC JAPAN, is a prominent peer-reviewed journal that serves the fields of medicine, pharmaceutical science, and pharmacology. With an ISSN of 0918-6158 and an E-ISSN of 1347-5215, this publication has been crucial in disseminating innovative research since its inception in 1993, and it continues to contribute significantly to the body of knowledge as it converges towards 2024. Despite being classified as a non-open access journal, it maintains a respectable Q3 ranking in Medicine (miscellaneous) and Q2 in Pharmaceutical Science, highlighting its critical role in advancing scientific discourse in these areas. With Scopus rankings placing it in the 51st percentile for Pharmaceutical Science and 38th percentile for Pharmacology, BIOLOGICAL & PHARMACEUTICAL BULLETIN is an essential resource for researchers, professionals, and students looking to stay abreast of cutting-edge developments and trends in biomedicine and drug development.

Current Molecular Pharmacology

Connecting Researchers to Cutting-edge Pharmacological Insights
Publisher: BENTHAM SCIENCE PUBL LTDISSN: 1874-4672Frequency: 7 issues/year

Current Molecular Pharmacology, published by Bentham Science Publishers, is a prominent journal focused on the dynamic fields of pharmacology, drug discovery, and molecular medicine. With an ISSN of 1874-4672 and an E-ISSN of 1874-4702, this journal aims to disseminate cutting-edge research and review articles that showcase innovative methodologies and groundbreaking findings from 2008 through 2024. Holding a respectable Q3 category ranking in Drug Discovery, Molecular Medicine, and Pharmacology for 2023, Current Molecular Pharmacology serves as an essential platform for both established researchers and emerging scholars to share their insights. The journal is indexed in Scopus with its relevant ranks catering to pharmacology and molecular biology, ensuring it reaches a wide array of professionals, researchers, and students in the field. As a contributor to advancing pharmacological sciences, this journal provides invaluable access to the latest advancements and fosters ongoing dialogue in molecular pharmacology, positioning itself as a key resource in the exploration of therapeutic agents and their interactions.

JOURNAL OF PHARMACY AND PHARMACOLOGY

Advancing pharmaceutical knowledge for a healthier tomorrow.
Publisher: OXFORD UNIV PRESSISSN: 0022-3573Frequency: 12 issues/year

Journal of Pharmacy and Pharmacology, published by Oxford University Press, is a prestigious academic journal dedicated to the advancement of knowledge in the fields of pharmaceutical sciences and pharmacology. With a strong heritage dating back to 1949, this journal maintains a robust influence, as evidenced by its ranking in the second quartile (Q2) across both Pharmaceutical Science and Pharmacology categories for 2023. The journal is accessible without an open access option, ensuring traditional academic engagement and providing valuable insights for researchers and professionals. It boasts an impressive Scopus ranking, with a percentile positioning of 72nd in Pharmaceutical Science and 67th in Pharmacology. Aimed at fostering innovative research and facilitating the exchange of cutting-edge scientific knowledge, the Journal of Pharmacy and Pharmacology serves as an essential resource for scientists, students, and healthcare professionals committed to enhancing therapeutic outcomes and advancing pharmaceutical innovations.

BRITISH JOURNAL OF PHARMACOLOGY

Pioneering insights into drug mechanisms and therapeutic innovations.
Publisher: WILEYISSN: 0007-1188Frequency: 24 issues/year

British Journal of Pharmacology is a premier, peer-reviewed journal published by Wiley, specializing in the dynamic field of pharmacology. With a robust impact factor, this journal ranks in the top quartile (Q1) for pharmacology according to the 2023 category rankings, emphasizing its significance and reputation among the global scientific community. As an essential resource for researchers, professionals, and students alike, the journal provides a platform for innovative research spanning foundational studies to clinical applications in pharmacology, toxicology, and pharmaceutics. Since its inception in 1966, the journal has consistently contributed to the advancement of pharmacological science, fostering a deeper understanding of drug action mechanisms and therapeutic advancements. Although primarily subscription-based, the British Journal of Pharmacology is committed to disseminating high-quality research that shapes the future of the field.

JOURNAL OF EVOLUTIONARY BIOCHEMISTRY AND PHYSIOLOGY

Illuminating Evolutionary Adaptations Through Biochemical Research
Publisher: PLEIADES PUBLISHING INCISSN: 0022-0930Frequency: 6 issues/year

JOURNAL OF EVOLUTIONARY BIOCHEMISTRY AND PHYSIOLOGY, published by PLEIADES PUBLISHING INC, is a pivotal periodical that delves into the intricate relationships between biochemical processes and evolutionary dynamics. With its ISSN 0022-0930 and E-ISSN 1608-3202, this journal serves as a comprehensive platform for researchers, professionals, and students dedicated to understanding the physiological adaptations and biochemical mechanisms influenced by evolutionary pressures. Although it is not an open access journal, it offers valuable insights across its historically significant coverage spanning from 1972 to 2017, making it an essential resource for those working in agricultural, biological, and molecular sciences. Despite its current Scopus rankings revealing limited visibility within its fields, the journal remains committed to fostering scholarly dialogue and advancing knowledge in the realm of evolutionary biochemistry, especially for those exploring the ecological, genetic, and integrative physiological aspects of life.

JOURNAL OF ETHNOPHARMACOLOGY

Transforming Traditional Practices into Modern Solutions
Publisher: ELSEVIER IRELAND LTDISSN: 0378-8741Frequency: 18 issues/year

The Journal of Ethnopharmacology, published by Elsevier Ireland Ltd, is a pivotal resource in the fields of Drug Discovery and Pharmacology, recognized as a Q1 journal in both categories as of 2023. With a rich history since its inception in 1979, this peer-reviewed journal provides a platform for rigorous research and innovative findings related to traditional medicinal practices and the therapeutic potential of natural products. The journal is ISSN 0378-8741 and E-ISSN 1872-7573, and it plays a vital role in advancing knowledge through its high-quality publications, which rank impressively at #35 out of 313 in Pharmacology and #19 out of 157 in Drug Discovery according to Scopus metrics. Although not open access, the journal aims to cater to a diverse audience of researchers, professionals, and students dedicated to exploring the intersection of ethnopharmacology and modern scientific inquiry. Its comprehensive scope encapsulates a multitude of studies spanning the globe, fostering a deeper understanding of how traditional practices can inform contemporary health solutions.

Frontiers in Physiology

Fostering collaboration in the realm of physiology.
Publisher: FRONTIERS MEDIA SAISSN: Frequency: 1 issue/year

Frontiers in Physiology, published by FRONTIERS MEDIA SA, is a leading open-access journal that has been at the forefront of physiological research since its inception in 2010. As a reputable publication based in Switzerland, it aims to foster the dissemination of groundbreaking findings across various domains of physiology, engaging a global audience of scholars and practitioners. With a commendable Q2 ranking in the fields of both general physiology and medical physiology for 2023, this journal stands out in its field, achieving a significant Scopus rank of #32/113 in medical physiology and #58/193 in biochemistry, genetics, and molecular biology. Frontiers in Physiology not only commits to maintaining high scholarly standards but also ensures that all its articles are freely accessible, thereby promoting collaborative knowledge exchange. With a clear focus on advancing our understanding of physiological processes, the journal plays a crucial role in the development of innovative approaches to health and disease, making it an essential resource for researchers, professionals, and students alike.

BIOSCIENCE REPORTS

Driving Progress in Biochemical and Cellular Research
Publisher: PORTLAND PRESS LTDISSN: 0144-8463Frequency: 6 issues/year

BIOSCIENCE REPORTS, published by Portland Press Ltd, is a prestigious journal dedicated to advancing the fields of biochemistry, biophysics, cell biology, and molecular biology. Founded in 1981, the journal has established itself as a vital resource for researchers and professionals, boasting a significant impact factor and high rankings within its categories, including Q2 in Biochemistry and Q1 in Biophysics as of 2023. The journal’s commitment to high-quality, peer-reviewed research ensures that it remains an influential platform for the dissemination of cutting-edge scientific findings. While it operates under a traditional subscription model, it offers various access options to accommodate the needs of the scientific community. With ongoing publication through 2024, BIOSCIENCE REPORTS continues to play a crucial role in shaping discussions in the life sciences and fostering innovative research in biology.

Biology-Basel

Fostering Collaboration in Cutting-edge Biological Discoveries
Publisher: MDPIISSN: Frequency: 12 issues/year

Biology-Basel is a premier, peer-reviewed open-access journal published by MDPI since 2012, situated in the heart of Switzerland. With an E-ISSN of 2079-7737, this journal serves as a vital platform for the dissemination of innovative research across the broad spectrum of Agricultural and Biological Sciences, Biochemistry, Genetics, Molecular Biology, and Immunology. Recognized for its rigorous editorial standards and impactful findings, it currently ranks Q1 in Agricultural and Biological Sciences and holds impressive positions in several categories according to the 2023 Scopus rankings. The journal’s open-access model ensures that high-quality research is freely available to a global audience, fostering collaboration and knowledge sharing among researchers, professionals, and students alike. Spanning from 2012 to 2024, Biology-Basel is committed to reflecting the latest advancements in biological sciences, making it an essential resource in the ever-evolving landscape of biological research.